BayBridge Capital Group’s Medtronic MDT Stock Holding History

BayBridge Capital Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	20,430 +3,052	+18%	+$246K	0.83%	35
2026 Q1	$1.67M	Hold	17,378	–	–	1.03%	30
2025 Q4	$1.67M	Buy	17,378 +59	+0.3%	+$5.73K	1.03%	30
2025 Q3	$1.65M	Buy	17,319 +214	+1%	+$19.7K	1.05%	29
2025 Q2	$1.49M	Buy	17,105 +354	+2%	+$30K	0.96%	34
2025 Q1	$1.51M	Buy	+16,751	New	+$1.5M	1.08%	27

Other funds holding MDT

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

BayBridge Capital Group's MDT Position: Q2 2026 in Review

BayBridge Capital Group increased its Medtronic (MDT) stake by 18% in Q2 2026, buying an estimated $246K and bringing the position to 20,430 shares worth $1.6M. The position accounts for 0.83% of the portfolio, ranked #35.

BayBridge Capital Group first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.67M in Q1 2026. 493 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

BayBridge Capital Group held 20,430 shares of Medtronic worth $1.6M as of Q2 2026.
BayBridge Capital Group bought 3,052 Medtronic shares in Q2 2026, an estimated $246K.
Medtronic made up 0.83% of BayBridge Capital Group's portfolio in Q2 2026, its #35 holding.
BayBridge Capital Group first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
BayBridge Capital Group's Medtronic position peaked at $1.67M in Q1 2026.
493 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on BayBridge Capital Group's 13F filing for Q2 2026, filed 14 Jul 2026.